qianjiang yongan pharm-a
Transactions by QIANJIANG YONGAN PHARM-A (002365) in the last 6 months
Hubei Ling'an Technology Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 33,330,000 on March 2, 2019. The transaction involved participation from existing investor Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) for CNY 16,931,600, Zhang Yong for CNY 13,248,800, Xia Changpei for CNY 2,266,400 and Dai Liang for CNY 883,200. Post the transaction, the registered capital of the company will increase from CNY 16,670,000 to CNY 50,000,000 ...
Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its class A shares. The shares will be repurchased at a price not more than CNY 15.70 per share. The repurchases will be funded using company's own funds. The shares repurchased will be used for ESOP or equity incentive plan. The program will be valid for 12 months.
The Board of Directors of Qianjiang ...
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|No competitor information is available for 002365.|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.